Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5200_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
52 Мб
Скачать
Itbansforeigncountriesfromreimportingprescriptiondrugsandthesale,trade,andpurchaseofany
drugsamples.
  It prohibits the resale of prescription drugs from hospitals, health care entities, and charitable
organizations.
Thepractitionermustaskfordrugsamplesinwriting.
  It regulates thewholesale distributionofprescriptiondrugs through the requirement of licensing in
stateswherefacilitiesarelocated.
Becausethesesamplesarefreelyavailable,someassumethatallpractitionerscandistributethem,but this is notthecase. Thepractitioner mustbe aware oftherules thatgovern requesting,receiving,and distributingtheseagentsbecausetheregulationsvaryfromstatetostate.
Accepting drug samples requires specific procedures. The pharmaceutical representative’s Sample RequestFormmustbesigned.Itincludesthename,strength,andquantityofthesample.Thesamplemust thenberecordedontheRecordofReceiptofDrugSamplesheet.Thesamplesmustbestoredawayfrom otherdruginventoriesandwhereunauthorizedaccessisnotallowedorinalockedcabinetorclosetina public area. Samples are to be inspected monthly for expiration dates, proper labeling and storage, presenceofintactpackagingandlabeling,andappropriatenessforthepractice.Ifasamplehasexpired, disposaloccursinamannerthatpreventsaccesstothegeneralpublic;itisnotdisposedintothetrash.
Whendistributingsamples,eachmustbelabeledwiththepatient’sname,cleardirectionsforuse,and cautions. All samples are to be dispensed free of charge, along with pertinent information. The medicationisthendocumentedinthepatient’schartwithdose,quantity,anddirections.
ADVERSEDRUGEVENTS
Prescription and nonprescription drugs have become an increasing part of life in the United States. Between 2013 and2016, 48.4% ofindividuals tookat leastoneprescriptiondruginthelast30 days (CDC,FastStats,2018). Adverse drugevents(ADE)haveconsequentlybecomeanincreasingproblem resulting in adverse events both in the inpatient and outpatient settings. Due to the magnitude of the problem, the Home of the Office of Disease Prevention and Health Promotion (2014) has created a National Action Plan for Adverse DrugEventPrevention (http://health.gov/hcq/ade.asp). Therefore, a prudentprescribermustalwaysbeawareofanymedicationswhenapatientispresentingforhealthcare. Chapter3reviewstheimpactofADEindepth.
LackofDrugKnowledge
Duetothesheernumberofprescriptiondrugs,prescribersmusthavecurrentknowledge.Prescriberscan lack knowledge about indications and contraindications for drugs. They must understand the pharmacodynamicsandpharmacokineticsofmedicationstoordermedicationsafely.
Dosingerrorscanoccur,especiallywhenprescribingforchildren.Theseerrorscanbeattributedtothe limitedinclusionofpediatricpatientsindrugstudies(Meyersetal.,2020).
Lack of knowledge about drug–drug interactions can also cause errors. For example, many drugs interferewithwarfarinandcauseincreasedbleedingiftakentogether.Theprescribermustbeawareof thepotentialfordrug–druginteractions(seeChapter3formoreinformation).
LackofPatientInformation
A standard error in prescribing is the failure to obtainanadequate history from the patient. Often, a satisfactory drug history is not obtained, and the provider does not specifically inquire about herbal preparationsorOTCmedications.Asmentionedpreviously,patientsdonotthinkOTCmedicationsare drugs and, therefore, do not include them on intake documents. Also, information on allergies to medicines is not reviewed. In addition to allergies, it is imperative to ascertain the reaction to the medication. While nausea is not considered an allergic reaction, the prescriber would not want to prescribe the drug. An allergy history should be taken and documented at each visit before a new medicationisprescribed.Additionally,askingmultipletimesaboutallergiesorreactionstodrugsduring anofficevisitisasafetycross-checktoresponsibleprescribing.
PoorCommunication
Poor communication among health care providers, pharmacists, and patients can be a result of poor handwriting,incorrectabbreviations,misplaceddecimals,andmisunderstandingofverbalprescriptions. Thesepotentialerrorscanbemitigatedusingelectronichealthrecords(EHR);however,newerrorscan occur if the practitioner does not click on the correct medication or enter the right directions. Additionally, there are areas in the UnitedStates where providers still handwriteprescriptions. Poor communicationalso resultswhentheprescriber fails todiscusspotentialside effectsor askaboutside effectsatsubsequentvisits.
SPECIALPOPULATIONCONSIDERATIONS
Dosesforchildrenareusuallybasedontheweightinkilograms.Theprescriberhasa responsibilityto calculateandwritethecorrectdoseratherthanrelyingoncalculationbythepharmacist.SeeChapter4 formoreinformationaboutpediatricdrugdosing.
Older patients may have some difficulty hearing or reading small print. Additionally, they may be takingmultipleprescriptionmedicationsandOTCmedications.Theprescriberneedstobespecificabout whenthepatientshouldtakeeachmedicationandifonedrugcannotbeadministeredwithothers.When the practitioner prescribes for older adults, he or she must consider renal function because some medicinescancausetoxicity,eveninsmalldoses,withdecreasedrenalfunction.Chapter5reviewsthe considerationsnecessaryforgoodprescribinginolderadults.
PHARMACOGENOMICS
Recently, the role of pharmacogenomics in prescribing medication is gaining more importance. Many differentgenesinfluencethewayapersonrespondstoadrug.Withoutknowingallthegenesinvolvedin drugresponse,ithasnotbeenpossibletodevelopgeneticteststhatcouldpredictaperson’sresponsetoa drug. Knowing that people’s genes show small variations in the DNA base makes genetic testing for predictingdrugresponsepossible.Geneticfactorscanaccountfor20%to95%variabilityinthepatient’s reactiontoadrug.Whenpharmacogenetictestingisavailable,itcanenableproviderstounderstandwhy patientsreactdifferentlytovariousdrugsandtomakebetterdecisionsabouttherapy.Thisunderstanding mayallowforhighlyindividualizedtherapeuticregimens.ThisconceptisdiscussedindetailinChapter
7.
STEPSOFTHEPRESCRIBINGPROCESS
Ateachvisit,theprescriberobtainsamedicationhistorywiththenameofthedrug,dosage,andfrequency ofadministration.Additionally,theinformationonanyallergiesshouldalsobereviewedordocumented. Itisalsohelpfulifthepatientbringshisorheractualdrugstothevisit.
Multiplesteps(Figure1.2)areinvolvedinprescribingdrugsandevaluatingtheireffectiveness.Again, thefirststepisdetermininganaccuratediagnosisbasedonthepatient’shistory,physicalexamination,and pertinenttestfindings.
Next,inselectingthebestagent,thepractitionerthoroughlyevaluatesthepatient’scondition,takinginto considerationtheeffectthatvariousmedicationsmayhaveonthepatientandthedisorder,theexpected outcomesoftherapy,andothervariables(Box1.3).Toprescribeanydrugtherapy,thepractitionermust havesubstantialknowledgeandbackgroundinthepathophysiologyofthedisease,pharmacotherapeutics, pharmacokinetics,pharmacodynamics,andanyinteractions(seeChapter2).
Thepractitionerneedstobeknowledgeableaboutthebestclassofdrugsforthediagnoseddisorderor presenting problem, the recommended dosage, potential side effects, possible interactions with other medications,andspecialprescribingconsiderations,suchasrequiredlaboratorytests,contraindications, andpatientinstructions.
FIGURE1–2Processforprescribing.
Box1.3 VariablestoConsiderinPrescribingaMedication
Age
Sex
Race
Weight
Culture
Allergies
Pharmacogenomics
Otherdiseasesorconditions
Othertherapies
Prescriptionmedications
Over-the-countermedicines
Alternativetherapies
Previoustherapies
Effectiveness
Adverseeffects
Adherence
Socioeconomicissues
Insurancestatus
Incomelevel
Dailyschedule
Livingenvironment
Supportsystems
Healthbeliefs
Next,thepractitioner sets goals fortherapy. Goalsneedtobe patientcentered andrealistic andthe outcomesmeasurable.Evaluationofanytreatment,nonpharmacologicorpharmacologic,isbasedonthe results.
SelectingtheMostAppropriateAgent
For most disease entities, there is a recommendation for firstline, second-line, and third-line therapy. Therapiesareidentifiedbyevidence-basedresearch,whichshowsspecificagentstobemoreeffective thanothers.Foreachrecommendedtreatmentline,theprescriberevaluatestheeffectivenessandpotential sideeffects.Thepatientresponseandpreferencesdictatechangesinthedrugs.Formoreinformation,see thechaptercasestudyoutliningtheprescribingprocess.Casestudiesthatemphasizetheseprocesseshave beenprovidedthroughoutthetext.
ConsiderationofSpecialPopulations
Anotherstepinprescribingdrugsisconsideringspecificconcernsrelatedtospecialpopulations,suchas children, pregnant or breast-feeding women,andolder adults. Cultural beliefs are also considered to ensurethatthedrugregimenhonorsindividualandfamilycustomsandpreferences.
IdentifyingOutcomes
Expected outcomes can include improvement in clinical symptoms or pathologic signs or changes in biochemistryasdeterminedbylaboratorytests.Toassesswhetherexpectedresultshavebeenachieved, thepractitionerreviewsdatacollectedonsubsequentvisits,evaluatestheeffectivenessofdrugtherapy, andinvestigatesanyadversereactions.
Thefrequencyoffollow-upvisitsisdeterminedbythediseaseandthepatient’sresponsetotreatment. Whileoutcomesarebeingassessed,thepractitionereducatesthepatientabouttheresultsoftherapyas well. Topics for discussion include drug benefits, side effects, dosage adjustments, and monitoring parameters.
Anundesirableoutcomecanoccurwithanymedication.Practitionersneedtoadvisepatientsaboutthe potentialsideeffectsandadvisethemtoreportissuesrelatedtothedrugs.Reactionsthatmaybeexpected andmustbediscussedincludesideeffects,drugorfoodinteractions,andtoxicity.Ifapatientexperiences aseriousadverse drugreaction,thepractitionerfiles areportwiththeFDA’sMedWatchprogramona special form obtainable from MedWatch (5600 Fishers Lane, Rockville, Maryland 20852-9787) or reportsitonline,athttps://www.accessdata.fda.gov/scripts/medwatch/(seeChapter3forasampleofthe MedWatch form). Similarly, adverse reactions to vaccines are reported through the Vaccine Adverse Event Reporting System (VAERS) online, at http://vaers.hhs.gov/esub/index-#Online, or by mail by completingaVAERSformrequestedbycalling1-800-822-7967andmailingittoVAERS,P.O.Box1100, Rockville,Maryland20849-1100.AdverseeventsarediscussedinChapter3.
WRITINGTHEPRESCRIPTION
Thepracticeofhandwritingprescriptionsisquicklybecominganexerciseofthepast;however,thereare still rare instances where a practitioner needs to know the steps. A prescription is a form of communicationbetweenthepractitionerandthepharmacist.Itisalsothebasisforwrittendirectionsto patients, and it is a legal document.Each prescription should be distinctlywritten to avoid errors of misinterpretationinfillingtheprescription.Althoughpotentiallyseriouserrors occurinfrequently, they areavoidableandshouldnotoccuratall.
Anearlystepintheprescribingprocessinvolvesensuringthatfrequentandpotentiallysevereerrors arenotmade.Thefirststepisafailuretoidentifyapatient’sallergies,particularlytoamedication.In determiningadrugallergy,thepractitionershouldalsoinvestigatethekindofreactionexperiencedwith themedicationtodifferentiatebetweenareal,life-threateningdrugallergyandlessacutedrugsensitivity. Some cross-sensitivities between categories of medication classes must also be considered. Another erroristhefailuretoinstructthepatienttostopapreviouslyprescribedmedicationthattreatsthesame condition,suchasanincreaseindose,andthepatientdoesnotstoptheotherdrug.Drug–druginteractions areessentialtoconsiderwhenprescribing.Therearenowprogramsthatcanperformmultiplechecksfor interactions.OneoftheseisEpocratesformobiledevicesanddesktops.
Date,Name,Address,andDateofBirth
Therearestandardcomponentsofanyprescription.Oneisthedate,andanotheristhefullname,address, anddateof birthofthepatient.Theperson’sname should be thepatient’s givenname(theoneonthe medicalrecord)andnotanickname.Ifadifferentnameisusedeachtime,thepatientcouldhavemultiple filesinpharmacyrecord-keepingsystems.Theaddressshouldbethecurrenthomeaddressofthepatient andnotaworkaddressorapostofficebox.
Prescriber’sName,Address,andPhoneNumber
Statelaws mandateprescribingpads tocontainthename, address,andphonenumberoftheprescriber and,if required bystate law or regulations,the collaboratingphysician. This information enables the pharmacisttocontacttheprescriberifthereisaquestionabouttheprescription.
NameofDrug
Ofcourse,thenameofthedrugisanessentialpartoftheprescription.Ideally,thegenericname(withthe tradeor brandnameinparentheses) needsto be used.Legiblywritingthedrugnameavoidserrors in fillingtheprescriptioncorrectly. For instance,somedrugshave namesthatarecommonlyconfused or misread,suchasNorvascandNavane,PrilosecandProzac,carboplatinandcisplatin,andLevoxineand Lanoxin. Severe problems may result if the wrong drug is supplied erroneously. The diagnosis may optionally be added to the prescription, which can help the pharmacist avoid misinterpreting the prescribedmedication.
Dose,DosageRegimen,andRouteofAdministration
The drug dose is essential because many drugs are available in various strengths. Write the dose in numerals.Ifthedoseisafractionof1,itiswrittenindecimalformwithaleadingzerototheleftofthe decimalpoint(e.g.,0.75).However,awholenumbershouldnotbefollowedbyadecimalpointanda trailingzero (“10.0” could be misreadas “100”).Thenumeric dose isfollowedbythecorrectmetric specification,suchasmilligram(mg),gram(g),milliliter(mL),ormicrogram(mcg).Manypractitioners spelloutmicrogramtoavoidconfusionwithmilligram.Somedrugsaremanufacturedinunitsthatshould bespecified,andthetermunitshouldbe writtenout(“insulin10units,”not“10 U”). There aremany combinationdrugs,anditisimportanttodesignatethestrengthofeachmedication.Anexampleoftwo drugsinonetabletislosartan25 mg/hydrochlorothiazide12.5mg—this drugalso formulateddifferent dosecombinationswithoutdosespecificityerrorsinprescribing.
Theprescriptionalsomentionshowfrequentlythedrugistobetaken.Adrugprescribedtobetakenas neededistermedaprndrug.Forexample,dosagefrequencycanbewrittenas“prnevery4hours”(or another appropriate interval) for the problem for which the drug is prescribed (e.g., “as needed for nausea”). It is good practice to write out the number (10—ten), especially with CSs. Any special instructions,suchas“aftermeals,”“atbedtime,”or“withfood,”alsoshouldbespecified.Ifthedoseis onceaday,itisasaferpracticetowriteout“daily”thantowrite“O.D.”becausethiscanbeconfused witheveryotherday.
The prescriptionalso includes the number of pills, vials, suppositories, or containers or amountin millilitersorouncestobedispensed.Prescriptionreimbursementorhealthcareinsuranceprogramsoften allowfor30-or90-daysuppliestobedispensedatatime;workingwiththepharmacistisimperativefor optimalprescribingpractices.Theyarethe bestconnectionregardingthe rules ofvariousprescription
plans. The prescription indicates whether the medicine may be refilled and the number of refills permitted.
Whenprescribinganewdrugforapatient,thepractitionermaywanttoconsiderprescribingjustafew doses or a 7-day supply initially, but this could be problematic with insurance paying for additional medicationsinthemonth.Inthatcase,anotheralternative,ifavailable,istoprovidesamples,ifallowed bylaworregulations.Thispracticeenablestheprescribertodetermineifthepatientcantoleratethedrug andifitiseffective.Whendecidingonthenumberofrefills,thepractitionermaydecidewhenthepatient shouldreturnforafollow-upvisitandallowjustthenumberofrefillsthatthepatientshouldtakeuntilthe nextvisittoensurethatthepatientreturnstotheoffice.Somedrugprescriptionscannotberefilled.Forall Schedule2drugs,forexample,anewprescriptionmustbewritteneachtime.
AllowableSubstitutions
Therearemanygenericequivalentsforbrandnamedrugs.Indicationofwhetherasubstitutionisallowed isapartoftheprescription.Generally,onprescriptionpads,thereisaspecificlinetosignforageneric replacement.Asdiscussedearlier,agenericdrugsubstitutemusthavethesamechemicalcompositionand dosageasthebrandnamedruginitiallyprescribed.Inmanystates,agenericdrugwillautomaticallybe substitutedforabrandnamedrug.Ifthereisamedicalreasontorequireabrandnamedrug(thathasa genericequivalent),“BrandMedicallyNecessary”mustbewrittenontheprescription.
Prescriber’sSignatureandLicenseNumber
Thesignatureoftheprescriberisrequired.Itshouldbelegibleandshouldbetheperson’slegalsignature. Thestateregulations varyregardingtheinclusionof the prescriber orcollaborating physician’license numberon theprescription.Insomeinstances,theNPInumber oftheprescriberis also required. The DEA numberis required forprescribingaCSandsometimesneededwhenprescribingbetweenstates.
Figure 1.3 illustrates a blank prescription and a completed prescription. Each state has specific
requirementsforobtainingthecomponentsonaprintedprescription.Thepractitionermustcomplywith stateregulations andmayprescribeonlyinthestate inwhichheorsheholds a license. Althoughthe prescription may be filled inanother state(ifallowed by stateregulations),a DEAnumber is usually required. An NPI number must be included on each prescription along with a serial number of the prescriptionform.Ifthepractitionerisafederalemployee,heorshemayprescribeinanyfederalfacility.
Any drug prescribed should be documented in the medical record with date of order, dosage, the amountprescribed,andthenumberofrefills.Itishelpfultohaveaspecificareainthemedicalrecordto record alldrugstakenbythepatient—prescription,OTC,andCAM—foreaseofaudit,reference,and communicationamonghealthcareprofessionals.
FIGURE1–3Exampleofablankprescriptionform(left)andacompletedform(right).
ElectronicPrescriptions
Electronicprescribinghasbecomeincreasinglypopular andmandatedbymanystates.Federally, CMS hasmandatedthatallPartDprescriptionsbe generatedelectronicallyfromJanuary2021 onward. The benefits of using health care technology are the reduction of medication errors with the use of drug­checkingsoftware, whichchecksthemedicationdose, potentialinteractionswithothermedicationsthe patientmaybetaking,andthepatient’sknownallergies.Thisdrug-checkingsoftwaremaybepartofthe EHRorafreestandinge-prescribingsystem.IntegratedEHRscancalculatedosingbasedonapatient’s weightandcarryoutothercontextualmedicationcheckingagainstapatient’slaboratoryresults,age,and disease states. Also, computer systems provide pick lists of frequently selected medications with a precalculated dose, frequency, and route. This list reduces the opportunity for clinicians to order inappropriateamountsofmedicationswiththewrongfrequencyandrouteofadministration.
E-prescribingimprovesthelegibilityofprescriptionsandtherateofcompletedprescriptions.There are manybenefits topatientswhenmedication is e-prescribed. Patientsnolonger needto carrypaper copiesofaprescriptiontoapharmacy,formulary-compliantmedicationsareprescribed,andtheorderis waitingforthemwhentheyarriveatthepharmacy.Therefore,e-prescribingleadstopatientconvenience, shorterwaittimes,andincreasedcompliancewithformularyrequirements.E-prescribinghasyieldeda 12%to20%decreaseinadversedrugreactions(Figge,2009).
ADHERENCEISSUES
A prescribed drug must be used correctly to produce optimal benefits. Patient nonadherence to a prescribedregimenleadstoless-than-optimaloutcomes,suchasprogressionofthediseasestateandan increasedincidenceofhospitalizations.Studiesdemonstratethatthemorecomplexthetreatmentregimen, thelesslikelythepatientistofollowit.Benner(2009)studied5,759patientstakingantihypertensiveand
lipid-loweringdrugs.Inpatientswith0,1,and2priormedications,41%,35%,and30%ofpatientswere adherent,respectively,toantihypertensiveandlipid-loweringtherapy.Ofpatientswith10ormoreprior medications,20%wereadherent.
Karter(2009) foundthat22% ofpatients hadthe prescriptionfilled0 or 1 time. The proportionof newlyprescribedpatientswhoneverbecameongoinguserswaseighttimesgreaterthantheproportion who maintained ongoing use but with inadequate adherence. Four percent of those who had the prescriptionfilledatleasttwotimesdiscontinuedtherapyduringthe24-monthfollow-up.Nonadherence wassignificantlyassociatedwithhighout-of-pocketcostsandclinicalresponsetotherapy.
Severalvariablesareassociatedwithimprovedadherencetoadrugregimen.Theseincludevariables associatedwiththepatient’sperceptionoftheencounterandofthebenefitofthetreatment.Ifapatientis nonadherent to the prescribed regimen, it is important to document that in the chart. The risks of nonadherencearediscussed,andthatdiscussionisdocumented.Itisessentialtoaskwhythepatientisnot following the prescribed treatment, and actions to rectify the problem should be taken. All of this is documented. One issue may be that the patient is unable to swallow the pill. The medicine may be available in liquid form, or the pill may be split or crushed. The practitioner needs to review and understandthefactorsthataffectadherencetoaregimen(Box1.4).
UPDATINGDRUGINFORMATION
Manysourcesofdruginformationcanbeaccessedbypractitioners,whomustkeepcurrentonchangesin drug therapy and continually update their fund of knowledge. Resources include reference books, pharmacists (who are expertly informed about drugs, interactions, dosages, etc.), easy-to-carry drug handbooksandpocketguidesforquickreference,andonlinedatabasesandprogramsformobiledevices anddesktopcomputers(Tables1.2and1.3).
Box1.4 FactorsInfluencingthePatient’sAdherencetoaMedicationRegimen
Approachabilityofthehealthcareprovider
Perceptionofrespectwithwhichthepatientistreatedbythepractitioner
Beliefthatthetherapyisbeneficial
Beliefthatthebenefitsoftherapyoutweightherisksorsideeffects
Degreetowhichthepatientparticipatesindevelopingthetreatmentregimen
Costoftheregimen
Simplicityoftheregimen
Patient’sunderstandingofthetreatmentregimen
Degreetowhichthepatientfeelsthatexpectationsarethepractitionerbeingmet
Degreetowhichthepatientperceiveshisorherconcernsareimportantandbeingaddressed
Degreetowhichthepractitionermotivatesthepatienttoadheretotheregimen
Degreetowhichtheregimeniscompatiblewiththepatient’slifestyle
TABLE1.2
CommonDrugReferenceBooks
Reference Features
AmericanHospitalFormulary Service.Bethesda,MD:American
SocietyofHealthSystem Pharmacists.
Drugentriesareindexedbygenericandbrandnamesandorganizedby pharmacologic–therapeuticclass.
DrugFactsandComparisons. Philadelphia,PA:WoltersKluwer Health.
Drugsareindexedbygenericandbrandnamesandorganizedbymajor classesofdrugs.Updatesareissuedmonthly(inprintandCD-ROM).
Physician’sDeskReference(PDR). Montvale,NJ:MedicalEconomics.
Drugsareindexedbymanufacturername,brandname,genericname,and productcategory.Volumecontainsproductidentificationsection.Information replicatestheofficialpackageinsertfromthedrugmanufacturer.
TABLE1.3
OnlineDrugReferenceData
Reference Address Features
AHRQ www.ahrq.gov GuidelinesforclinicalpracticefromtheAHRQ,NationalGuidelines
Clearinghouse,U.S.PreventiveServicesTaskForce
CenterWatch ClinicalTrials
www.centerwatch.com Listsclinicalresearchtrialsanddrugtherapynewlyapprovedbythe
U.S.FDAandtheFDANewDrugListingService
Coreynahman www.coreynahman.com Pharmaceuticalnewsandinformation
Givesachoiceofmanysitesforinformation Epocrates www.epocrates.com Websitewithdruginformation,interactions,etc. Mediconsult www.mediconsult.com Professional-andconsumer-focused
Detailedmedicalanddruginformation Medscape www.medscape.com Drugsearchdatabase
Linkstoonlinejournals RxList—The
InternetDrugIndex
www.rxlist.com Cross-indexofU.S.prescriptionproducts
AHRQ,AgencyforHealthcareResearchandQuality;FDA,FoodandDrugAdministration.
CASESTUDY1
ThefirstpatientintheclinictodayisA.J.,whoisa16–year–oldwhohasjuststartedsoccerpractice atschool.Shecomplainsofincreasedshortnessofbreathwithexerciseanddescribeshavingahard timecatchingherbreathwhensheruns,whichshedoesfivetosixtimesaweek.Shedoesnotwakeup atnightwithacoughorshortnessofbreathandhasnoproblemsatanyothertimeexceptinthespring whenthetreesstarttoblossom.ThesoccercoachadvisedA.J.’smothertoseekhealthcarebecause A.J.hadaverydifficulttimebreathingatpracticethatafternoon.A.J.alsohasahistoryofeczemaand seasonalallergiesforwhichshetakesanover-the-counterantihistaminewhensymptomsgetsevere.
Socialhistory:Nonsmoker.Livesinanurbanareawithmother,father,andbrother.Doesnotuse streetdrugs.
Familyhistory:Fatherhasahistoryofasthma. Physicalexamination:
Nose:Mucosapaleandboggybilaterally